Clinical trial

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

NCT03743376

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-12-12

PhasePHASE2

Study timeline

Study start (actual)2018-12-12Date precision: day

Registry last updated2022-05-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-1 Infectionunresolved

Interventions

UB-421(25 mg/kg) Q2WBIOLOGICAL

UB-421(25 mg/kg) Q4WBIOLOGICAL

Sponsors & collaborators

United BioPharmalead sponsor

National Taiwan University Hospitalcollaborator

Taipei Veterans General Hospital, Taiwancollaborator

Taoyuan General Hospitalcollaborator

Kaohsiung Medical University Chung-Ho Memorial Hospitalcollaborator

Kaohsiung Veterans General Hospital.collaborator

Mapped research locations

Kaohsiung CityTaiwan2 TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03743376 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.